XML 53 R43.htm IDEA: XBRL DOCUMENT
v3.25.3

Stock-Based Compensation (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract] |
Schedule of Stock-Based Compensation Expense | Total stock‑based compensation expense consists of the following:
| Three Months Ended |  | Nine Months Ended
| September 30, |  | September 30,
| 2025 |  | 2024 |  | 2025 |  | 2024
Restricted stock and RSUs expense | $ | 15,614 |  |  | $ | 14,375 |  |  | $ | 47,056 |  |  | $ | 44,052 |
Bonus Plan expense (see Note 11) | 1,754 |  |  | 1,057 |  |  | 5,406 |  |  | 11,237 |
ESPP expense (see Note 13) | 674 |  |  | 622 |  |  | 1,975 |  |  | 1,837 |
Stock grants expense | — |  |  | — |  |  | 600 |  |  | 600 |
DCP elective participant deferrals expense (see Note 12) | — |  |  | 43 |  |  | — |  |  | 130 |
Total stock-based compensation expense (1) | $ | 18,042 |  |  | $ | 16,097 |  |  | $ | 55,037 |  |  | $ | 57,856 |
(1)As of September 30, 2025 and December 31, 2024, $2,162 and $1,556 remained in Accruals and other current liabilities in the consolidated balance sheets, respectively. Total stock‑based compensation expense is included in the consolidated statements of operations as follows:
| Three Months Ended |  | Nine Months Ended
| September 30, |  | September 30,
| 2025 |  | 2024 |  | 2025 |  | 2024
Cost of subscriptions and licenses | $ | 984 |  |  | $ | 520 |  |  | $ | 3,034 |  |  | $ | 882 |
Cost of services | 563 |  |  | 705 |  |  | 1,871 |  |  | 2,343 |
Research and development | 5,601 |  |  | 5,018 |  |  | 16,654 |  |  | 14,981 |
Selling and marketing | 4,014 |  |  | 3,305 |  |  | 11,977 |  |  | 9,625 |
General and administrative | 6,880 |  |  | 6,549 |  |  | 21,501 |  |  | 30,025 |
Total stock-based compensation expense | $ | 18,042 |  |  | $ | 16,097 |  |  | $ | 55,037 |  |  | $ | 57,856 |
Schedule of Restricted Stock and Restricted Stock Unit Activity | The following is a summary of unvested RSUs activity and related information:
|  |  |  |  |  |  | Time- |  | Performance-
|  |  |  |  |  |  | Based |  | Based
|  |  |  |  |  |  | Weighted |  | Weighted
|  |  |  |  |  |  | Average |  | Average
|  |  | Time- |  | Performance- |  | Grant Date |  | Grant Date
| Total |  | Based |  | Based |  | Fair Value |  | Fair Value
| RSUs |  | RSUs |  | RSUs |  | Per Share |  | Per Share
Unvested, December 31, 2024 | 3,417,009 |  |  | 3,067,703 |  | (1) | 349,306 |  | (2) | $ | 45.45 |  |  | $ | 44.83 |
Granted | 1,764,488 |  |  | 1,547,982 |  |  | 216,506 |  | (3) | $ | 40.81 |  |  | $ | 40.53 |
Vested | (1,220,396) |  |  | (905,492) |  |  | (314,904) |  |  | $ | 43.87 |  |  | $ | 43.84 |
Forfeited and canceled | (175,389) |  |  | (167,503) |  |  | (7,886) |  |  | $ | 42.59 |  |  | $ | 52.53 |
Unvested, September 30, 2025 | 3,785,712 |  | (4) | 3,542,690 |  |  | 243,022 |  |  | $ | 43.97 |  |  | $ | 42.02 |
(1)Includes 175,928 time‑based RSUs granted during the three months ended March 31, 2022 to certain officers and key employees, which cliff vested on January 31, 2025. Additionally, includes 300,964 time‑based RSUs granted during the three months ended June 30, 2024 to certain officers, which vest 20% on each of December 15, 2025, 2026, 2027, 2028, and 2029. (2)Primarily relates to the 2024 annual performance period. Includes 162,038 performance‑based RSUs granted during the year ended December 31, 2022 with extraordinary terms, which are described below. (3)Primarily relates to the 2025 annual performance period. Includes 10,493 additional shares earned based on the achievement of 2024 performance goals for performance-based RSUs granted during the year ended December 31, 2024. (4)Includes 41,621 RSUs which are expected to be settled in cash.

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration